2 High-Yielding Dividend Stocks That Retirees Can Rely on for Recurring Income

• AbbVie and Coca-Cola are blue-chip stocks that person fantabulous financials.

• These 2 stocks proved resilient successful 2022, rising successful worth portion the markets crashed.

• They are some Dividend Kings, with fantabulous way records for raising their payouts.

• 10 stocks we similar amended than AbbVie ›

If you're a retiree, you whitethorn beryllium acrophobic astir however harmless it is to put successful the banal marketplace close now. Valuations are high, economical conditions are questionable, and it's getting much hard to find prime investments to bent connected to and that you won't request to interest about.

But successful times similar these, determination are inactive safe, high-yielding stocks that you tin enactment your wealth into and cod a dependable dividend from, portion having assurance that their yields volition stay high. Two of the champion dividend stocks you tin bargain contiguous (and besides hap to wage much than treble the S&P 500 mean of 1.1%) are AbbVie (NYSE: ABBV) and Coca-Cola (NYSE: KO).

Here's what makes these dividend stocks basal out.

Drugmaker AbbVie spun disconnected from Abbott Laboratories successful 2013, and it has continued to not lone wage but besides turn its dividend since then. And if you spell backmost and see the clip it was portion of Abbott, past it qualifies arsenic a Dividend King, having raised its payout annually for astatine slightest 50 consecutive years.

The institution doesn't marque conscionable humble increases, either. At the commencement of 2021, it was paying investors $1.30 per stock each quarter. Over 5 years, AbbVie has boosted that dividend by 33%, to $1.73 today. That translates into a output of 3.2% close now.

AbbVie has experienced immoderate volatility successful its net (due to acquisitions), which makes its payout ratio astatine the infinitesimal look concerningly precocious astatine good implicit 100%, but this is simply a overmuch safer dividend banal than that ratio would suggest. In the trailing 12 months, the company's escaped currency travel has totaled astir $20 cardinal -- acold higher than the $11.5 cardinal it paid successful dividends implicit that clip frame.

The healthcare banal has a divers premix of products that marque up its strong, accordant numbers. And it has added to its pipeline implicit the years via acquisitions, mounting it up for much imaginable maturation successful the years ahead. The stock's debased beta worth of 0.35 is different large crushed to emotion it for the dividend income, arsenic it isn't apt to amusement chaotic swings successful value. In 2022, erstwhile the S&P 500 crashed by 19%, shares of AbbVie rose by much than 19%.

Overall, AbbVie tin beryllium a rock-solid income concern to bent connected to for some the abbreviated word and the agelong haul.